Oragenics, Inc. operates as a development-stage company, which engages in research and development of potential therapies to fight infectious diseases including coronaviruses and multidrug-resistant organisms. Its technology and pipeline consist of antibiotics and genetically engineered bacterial strains. The company was founded by Jeffrey D. Hillman and Robert T. Zahradnik in November 1996 and is headquartered in Lakewood Ranch, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
3
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. Oragenics Inc market cap is $906,903.00.
52 week high is the highest price of a stock in the past 52 weeks, or one year. Oragenics Inc 52 week high is $1.11 as of November 17, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Oragenics Inc 52 week low is $0.1667 as of November 17, 2026.
Oragenics Inc stock price today is $0.198.
Oragenics Inc stock price yesterday was $0.201.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. Oragenics Inc's P/E ratio is -0.09.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. Oragenics Inc P/B ratio is 0.8177.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. Oragenics Inc 50-day moving average is $0.432.